Omega Healthcare Investors (OHI) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
24 Jul, 2026Company profile and strategy
Listed since 1992, with $11.4B in real estate investments and $16.1B enterprise value.
Operates 1,032 properties across the US, UK, and Jersey, with 93,961 beds and 92 operators.
Maintains investment grade credit (BBB-) and a 7.3% dividend yield.
Focuses on skilled nursing facilities (SNFs) with long-term triple net leases and diversified tenant base.
Experienced management team with decades of industry tenure.
Investment thesis and portfolio strengths
Delivers consistent growth, high yield, and strong balance sheet management.
Portfolio is diversified by geography and operator, minimizing regulatory and reimbursement risks.
Triple-net leases provide steady, predictable income with minimal near-term expirations.
70% of recent investments are with existing operators, supporting stable relationships.
UK market offers attractive yields and growth due to supply-demand imbalance.
Skilled nursing facilities as an asset class
SNFs are the primary post-acute discharge destination, offering lowest cost 24-hour care.
Primarily funded by Medicare and Medicaid, with stable reimbursement trends.
Regulatory restrictions limit new supply, supporting occupancy and pricing.
SNFs deliver higher investment yields than other healthcare real estate sectors.
Latest events from Omega Healthcare Investors
- Q3 2025 saw higher earnings, raised AFFO guidance, and expanded investment activity.OHI
Q3 20259 Jul 2026 - Strong 2025 results, major investments, and robust 2026 AFFO outlook support continued growth.OHI
Q4 20259 Jul 2026 - Q4 saw strong financial growth, low leverage, and a robust U.K.-driven investment pipeline.OHI
Q4 20248 Jul 2026 - Board and auditor approvals, asset sale rationale, and dividend policy updates highlighted.OHI
AGM 202610 Jun 2026 - Largest SNF REIT, strong financials, poised for growth with demographic tailwinds.OHI
Investor presentation3 Jun 2026 - CEO and CFO transitions in 2026 include succession plans, incentives, and consulting agreements.OHI
Proxy filing21 May 2026 - Q1 2026 saw strong earnings growth, higher AFFO, and increased guidance amid robust investment activity.OHI
Q1 202629 Apr 2026 - Proxy details strong 2025 results, performance-based pay, and leadership in ESG and governance.OHI
Proxy filing21 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.OHI
Proxy filing21 Apr 2026